Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

NCT00508820 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00508820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00508820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
February 1, 2005
Completion date
March 1, 2011
Enrollment
407 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic thrombocytopenic purpura, thrombocytopenia, thrombocytopenic purpura